OMERS acquires partial ONPATTRO royalty streams from Arbutus for US $20M
2019-07-02
OMERS acquired Arbutus Biopharma’s portion of royalty interest on future global net sales of ONPATTRO (patisiran) for US $20MRead More →
MicroSintesis secures $16.4M funding from Northern Private Capital
2019-06-26
MicroSintesis of Charlottetown, PEI and Oakville, Ontario, raised $16.4 million from John Risley’s Nothern Private Capital (NPC) Read More →
Gradient Ventures makes add-on investment in BenchSci
2019-06-25
BenchSci raised additional investment from Gradient Ventures, Google’s AI-focused venture fund, that brings its total funding to US $20.5 million. Read More →
MEDTEQ announces co-investments in 8 HealthTech companies
2019-06-13
MEDTEQ, along with Anges-Quebec, Anges-Quebec Capital, Innovacorp, Real Ventures, invested in Densitas, MIMs (My Intelligent Machines), My01, Optina Diagnostics, Saccade Analytics, Spinologics, Spring Loaded Technology, THORASYS Read More →
Ampersand’s NEOMED closes 2nd add-on acquisition of PAIRimmune
2019-06-06
Ampersand Capital Partners owned NEOMED Laboratory acquired PAIRimmune from Danielle Poirier, Matthieu Daugan, Daniel LarocqueRead More →
Meridian closes US $120M acquisition of Debiopharm’s GenePOC
2019-06-03
Meridian Bioscience acquired the business of GenePOC from majority shareholder Debiopharm Group, Dr. Michel Bergeron, and others for up to US $120MRead More →
BDC Capital provides $2M SR&ED facility to Nutrasource
2019-06-03
BDC Capital Growth and Transition Capital provided $2M SR&ED facility to Nutrasource Pharmaceutical and Nutraceutical ServicesRead More →
eSight announces new CEO Kevin Banderk and $10M funding
2019-05-30
eSight announced the promotion of Kevin Banderk to CEO and closing of $10M debenture funding round to support new technology development and international expansion.
Read More →
Noblegen completes $25M series B led by Richardson Ventures
2019-05-30
Noblegen completed $25M Series B financing with Richardson Ventures Inc., BDC Capital Cleantech Practice, and other investors. Read More →
Forcen secures $500K seed financing led by NorthSpring Capital Partners
2019-05-27
Forcen, formerly SensOR Medical Laboratories, secured $500K seed funding from NorthSpring Capital Partners and Golden Triangle Angel Network (GTAN) and Angel One members Read More →
CPPIB acquires partial royalty interest in Keytruda from LifeArc for US $1.3B
2019-05-20
Canada Pension Plan Investment Board acquired a portion of LifeArc’s royalty interests on worldwide sales of Keytruda®* (pembrolizumab) for US $1.297B Read More →
BVF backed ESSA Pharma and Realm Therapeutics to combine
2019-05-16
Blackstone Clarus, Omega Fund, and BVF backed ESSA Pharma to acquire BVF backed Realm Therapeutics in US $21.5M all-stock transactionRead More →
